Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1984 July; 77(7): 585–594.
PMCID: PMC1439939

Screening for familial medullary thyroid carcinoma: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baylin SB, Wells SA., Jr Management of hereditary medullary thyroid carcinoma. Clin Endocrinol Metab. 1981 Jul;10(2):367–378. [PubMed]
  • Becker KL, Silva OL, Snider RH, Moore CF, Geelhoed GW. The surgical implications of hypercalcitonemia. Surg Gynecol Obstet. 1982 Jun;154(6):897–908. [PubMed]
  • Block MA, Jackson CE, Greenawald KA, Yott JB, Tashjian AH., Jr Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications. Arch Surg. 1980 Feb;115(2):142–148. [PubMed]
  • Body JJ, Heath H., 3rd Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. J Clin Endocrinol Metab. 1983 Nov;57(5):897–903. [PubMed]
  • Brown MJ, Allison DJ, Jenner DA, Lewis PJ, Dollery CT. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet. 1981 Jan 24;1(8213):174–177. [PubMed]
  • Carney JA, Hayles AB. Alimentary tract manifestations of multiple endocrine neoplasia, type 2b. Mayo Clin Proc. 1977 Sep;52(9):543–548. [PubMed]
  • Carney JA, Roth SI, Heath H, 3rd, Sizemore GW, Hayles AB. The parathyroid glands in multiple endocrine neoplasia type 2b. Am J Pathol. 1980 May;99(2):387–398. [PubMed]
  • Cerny JC, Jackson CE, Talpos GB, Yott JB, Lee MW. Pheochromocytoma in multiple endocrine neoplasia type II: an example of the two-hit theory of neoplasia. Surgery. 1982 Nov;92(5):849–852. [PubMed]
  • Chong GC, Beahrs OH, Sizemore GW, Woolner LH. Medullary carcinoma of the thyroid gland. Cancer. 1975 Mar;35(3):695–704. [PubMed]
  • Deftos LJ, Weisman MH, Williams GW, Karpf DB, Frumar AM, Davidson BJ, Parthemore JG, Judd HL. Influence of age and sex on plasma calcitonin in human beings. N Engl J Med. 1980 Jun 12;302(24):1351–1353. [PubMed]
  • Dyck PJ, Carney JA, Sizemore GW, Okazaki H, Brimijoin WS, Lambert EH. Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol. 1979 Oct;6(4):302–314. [PubMed]
  • Dymling JF, Ljungberg O, Hillyard CJ, Greenberg PB, Evans IM, MacIntyre I. Whisky: a new provacative test for calcitonin secretion. Acta Endocrinol (Copenh) 1976 Jul;82(3):500–509. [PubMed]
  • Emmertsen K, Elbrønd O, Nielsen HE, Mosekilde L, Charles P, Kaae S, Hansen HH. Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatment. Eur J Cancer Clin Oncol. 1982 Jul;18(7):645–650. [PubMed]
  • Emmertsen K, Ernø H, Henriques U, Schrøder HD. C-cells for differentiation between familial and sporadic medullary thyroid carcinoma. Dan Med Bull. 1983 Sep;30(5):353–356. [PubMed]
  • Emmertsen KK, Nielsen HE, Mosekilde L, Hansen HH. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid. Acta Radiol Oncol. 1980;19(2):85–89. [PubMed]
  • Fletcher DR. Medullary carcinoma of thyroid and phaeochromocytoma. J R Soc Med. 1978 Apr;71(4):289–291. [PMC free article] [PubMed]
  • Gagel RF, Jackson CE, Block MA, Feldman ZT, Reichlin S, Hamilton BP, Tashjian AH., Jr Age-related probability of development of hereditary medullary thyroid carcinoma. J Pediatr. 1982 Dec;101(6):941–946. [PubMed]
  • Gorlin RJ, Sedano HO, Vickers RA, Cervenka J. Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid--a syndrome. Cancer. 1968 Aug;22(2):293–passim. [PubMed]
  • Graze K, Spiler IJ, Tashjian AH, Jr, Melvin KE, Cervi-Skinner S, Gagel RF, Miller HH, Wolfe HJ, DeLellis RA, Leape L, et al. Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis. N Engl J Med. 1978 Nov 2;299(18):980–985. [PubMed]
  • Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. [PubMed]
  • Heath H, 3rd, Sizemore GW. Radioimmunoassay for calcitonin. Clin Chem. 1982 May;28(5):1219–1226. [PubMed]
  • Hillyard CJ, Myers C, Abeyasekera G, Stevvensvenson JC, Craig RK, MacIntyre I. Katacalcin: a new plasma calcium-lowering hormone. Lancet. 1983 Apr 16;1(8329):846–848. [PubMed]
  • Jackson CE, Block MA, Greenawald KA, Tashjian AH., Jr The two-mutational-event theory in medullary thyroid cancer. Am J Hum Genet. 1979 Nov;31(6):704–710. [PubMed]
  • Kan YW, Dozy AM. Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5631–5635. [PubMed]
  • Melvin KE, Tashjian AH, Jr, Miller HH. Studies in familial (medullary) thyroid carcinoma. Recent Prog Horm Res. 1972;28:399–470. [PubMed]
  • Murray JM, Davies KE, Harper PS, Meredith L, Mueller CR, Williamson R. Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature. 1982 Nov 4;300(5887):69–71. [PubMed]
  • Norton JA, Froome LC, Farrell RE, Wells SA., Jr Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. Surg Clin North Am. 1979 Feb;59(1):109–118. [PubMed]
  • Riley FC, Jr, Robertson DM. Ocular histopathology in multiple endocrine neoplasia type 2b. Am J Ophthalmol. 1981 Jan;91(1):57–64. [PubMed]
  • Roos BA, Huber MB, Birnbaum RS, Aron DC, Lindall AW, Lips K, Baylin SB. Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin. J Clin Endocrinol Metab. 1983 Apr;56(4):802–807. [PubMed]
  • Rougier P, Parmentier C, Laplanche A, Lefevre M, Travagli JP, Caillou B, Schlumberger M, Lacour J, Tubiana M. Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys. 1983 Feb;9(2):161–169. [PubMed]
  • Samaan NA, Anderson GD, Adam-Mayne ME. Immunoreactive calcitonin in the mother, neonate, child and adult. Am J Obstet Gynecol. 1975 Mar 1;121(5):622–625. [PubMed]
  • Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, Tobes MC, Beierwaltes WH, Thompson NW. Scintigraphic localization of pheochromocytoma. N Engl J Med. 1981 Jul 2;305(1):12–17. [PubMed]
  • Stevenson JC, Hillyard CJ, Spanos E, MacIntyre I, Ackroyd N, Lynn J, Brown MJ, Stevenson BM. Sipple syndrome: marked variability of the disease within a family and implications for management. Postgrad Med J. 1981 Feb;57(664):104–108. [PMC free article] [PubMed]
  • Stewart BH, Bravo EL, Haaga J, Meaney TF, Tarazi R. Localization of pheochromocytoma by computed tomography. N Engl J Med. 1978 Aug 31;299(9):460–461. [PubMed]
  • Telenius-Berg M, Almqvist S, Berg B, Hedner P, Ingemansson S, Tibblin S, Wasthed B. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests. Eur J Clin Invest. 1977 Feb;7(1):7–16. [PubMed]
  • Valk TW, Frager MS, Gross MD, Sisson JC, Wieland DM, Swanson DP, Mangner TJ, Beierwaltes WH. Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med. 1981 Jun;94(6):762–767. [PubMed]
  • Verdy M, Cholette JP, Cantin J, Lacroix A, Sturtridge WC. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma. Can Med Assoc J. 1978 Jul 8;119(1):29–35. [PMC free article] [PubMed]
  • Webb TA, Sheps SG, Carney JA. Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrime neoplasia, type 2. Am J Surg Pathol. 1980 Apr;4(2):121–126. [PubMed]
  • Wells SA, Jr, Baylin SB, Gann DS, Farrell RE, Dilley WG, Preissig SH, Linehan WM, Cooper CW. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg. 1978 Sep;188(3):377–383. [PubMed]
  • Wells SA, Jr, Baylin SB, Linehan WM, Farrell RE, Cox EB, Cooper CW. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg. 1978 Aug;188(2):139–141. [PubMed]
  • Wells SA, Jr, Baylin SB, Leight GS, Dale JK, Dilley WG, Farndon JR. The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg. 1982 May;195(5):595–599. [PubMed]
  • Wolfe HJ, Delellis RA. Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab. 1981 Jul;10(2):351–365. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press